mrg003
mAbexperimentalADC
Clinical trial activity
16 trials · 16 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
14
Phase 3
2
Phase 4
0
Earliest trial started May 9, 2018 (NCT04868344)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Payload
- Monomethyl auristatin E
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL6068210 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07267338 | Phase 2 | Jun 30, 2026 | Huazhong University of Science and Technology, Lepu Medical Technology (Beijing) Co., Ltd., Merck |
| NCT07303283 | Phase 2 | Mar 1, 2026 | First People's Hospital of Yulin, Guangxi Medical University, Guigang People's Hospital, Lingshan people's Hospital, North Sichuan Medical University, Wuzhou Red Cross Hospital |
| NCT06959108 | Phase 2 | Oct 31, 2025 | Groupe Oncologie Radiotherapie Tete et Cou, GROUPE ONCOLOGIE RADIOTHERAPIE TETE ET COU, Lepu Medical Technology (Beijing) Co., Ltd. |
| NCT07054307 | Phase 1 | Jul 30, 2025 | Lepu Medical Technology (Beijing) Co., Ltd., Sichuan University |
| NCT06976190 | Phase 3 | May 31, 2025 | Shanghai Miracogen Inc., Sun Yat-Sen University |
| NCT07235566 | Phase 2 | Apr 21, 2025 | Fudan University |
| NCT06530914 | Phase 2 | Aug 1, 2024 | Sichuan University |
| NCT06509997 | Phase 2 | Aug 1, 2024 | Sichuan University |
| NCT05751512 | Phase 3 | Mar 31, 2023 | Huazhong University of Science and Technology, Shanghai Miracogen Inc. |
| NCT05688605 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2022 | Shanghai Miracogen Inc., Sun Yat-Sen University |
| NCT05126719 | Phase 2 | Aug 4, 2021 | Shanghai Miracogen Inc., Sun Yat-Sen University |
| NCT05188209 | Phase 2 | May 24, 2021 | Chinese Academy of Medical Sciences, Shanghai Miracogen Inc. |
| NCT04838964 | Phase 2 | Apr 30, 2021 | Chinese Academy of Medical Sciences, Shanghai Miracogen Inc. |
| NCT04868162 | Phase 2 | Apr 23, 2021 | Huazhong University of Science and Technology, Shanghai Miracogen Inc. |
| NCT04838548 | Phase 2 | Sep 4, 2020 | Chinese Academy of Medical Sciences, Shanghai Miracogen Inc. |
| NCT04868344 | Phase 1 | May 9, 2018 | Shanghai Miracogen Inc., Sun Yat-Sen University |
Showing 16 of 16 trials
Page 1 / 1
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Miracogen Inc. | For profit | 9 | 9 | 3 | 2018 |
| Sun Yat-Sen University | Academic/Hospital | 4 | 0 | 3 | 2018 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 3 | 0 | 1 | 2020 |
| Huazhong University of Science and Technology | Academic/Hospital | 3 | 1 | 2 | 2021 |
| Lepu Medical Technology (Beijing) Co., Ltd. | For profit | 3 | 0 | 2 | 2025 |
| Sichuan University | Academic/Hospital | 3 | 3 | 2 | 2024 |
| First People's Hospital of Yulin | Academic/Hospital | 1 | 0 | 1 | 2026 |
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Groupe Oncologie Radiotherapie Tete et Cou | Academic/Hospital | 1 | 1 | 1 | 2025 |
| GROUPE ONCOLOGIE RADIOTHERAPIE TETE ET COU | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Guangxi Medical University | Academic/Hospital | 1 | 1 | 1 | 2026 |
| Guigang People's Hospital | Academic/Hospital | 1 | 0 | 1 | 2026 |
| Lingshan people's Hospital | Academic/Hospital | 1 | 0 | 1 | 2026 |
| Merck | For profit | 1 | 0 | 1 | 2026 |
| North Sichuan Medical University | Academic/Hospital | 1 | 0 | 1 | 2026 |
| Wuzhou Red Cross Hospital | Academic/Hospital | 1 | 0 | 1 | 2026 |
16 organizations
Page 1 / 1